Hospitals | May 20, 2022
Sparsh Hospital introduces ‘Infinite care’ joint replacement programme
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
The centres will be located in Tier I and Tier II cities
Multiples is the first private equity (PE) investor in the company
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program
In clinical trials, treatment proved more effective than other therapies evaluated
The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries
Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
